Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

But beware. Health and Human Services Secretary Robert F. Kennedy, Jr. has called for “conflict-free” advisory committee ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Mallinckrodt plc and Endo Inc. said Thursday they are combining in a stock and cash deal with an enterprise value of $6.7 billion.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cartesian Therapeutics (RNAC – Research Report) ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on PDS Biotechnology (PDSB – Research Report) and Cartesian ...

In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.

But as the drugstore chain (WBA) prepares to go private and its rival CVS Health Inc. (CVS) experiments with smaller stores, some analysts and researchers see a possible future with even fewer ...

The Indian e-commerce industry is projected to reach US$ 325 billion by 2030, experiencing significant growth. * Third-party logistics providers are anticipated to manage approximately 17 billion ...

Bacil Pharma Ltd., incorporated in the year 1987, is a Small Cap company (having a market cap of Rs 21.57 Crore) operating in Pharmaceuticals sector. Bacil Pharma Ltd. key Products/Revenue Segments ...

Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is ...